Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus.

Li S, Li Z, Hou X, Sun J, Kang L, Cheng Y, Tao Y, Li Z, Chen X, Zhang D, Yan X, Wang S, Gao Y, Wang Q, Lin Y, Yin C, Zhang J, Gao Y, Huang J, Wu X, Li N, Su W, Liu H, Sun T.

J Int Med Res. 2019 Jun 13:300060519842777. doi: 10.1177/0300060519842777. [Epub ahead of print] No abstract available.


Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost.

Abdelnoor M, Andersen JG, Arnesen H, Johansen O.

Vasc Health Risk Manag. 2017 Mar 20;13:101-109. doi: 10.2147/VHRM.S122951. eCollection 2017. Review.


Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome.

Morici N, Savonitto S, Ponticelli C, Schrieks IC, Nozza A, Cosentino F, Stähli BE, Perrone Filardi P, Schwartz GG, Mellbin L, Lincoff AM, Tardif JC, Grobbee DE.

Am J Med. 2017 Sep;130(9):1068-1075. doi: 10.1016/j.amjmed.2017.02.033. Epub 2017 Mar 24.


Defining operative mortality: Impact on outcome reporting.

Maximus S, Milliken JC, Danielsen B, Khan J, Shemin R, Carey JS.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):1101-7. doi: 10.1016/j.jtcvs.2015.10.062. Epub 2015 Oct 27.


Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention.

Massalha S, Luria L, Kerner A, Roguin A, Abergel E, Hammerman H, Boulos M, Dragu R, Kapeliovich MR, Beyar R, Nikolsky E, Aronson D.

Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):455-462. Epub 2015 Jul 30.


Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Li C, Sun Y, Shen X, Yu T, Li Q, Ruan G, Zhang L, Huang Q, Zhuang H, Huang J, Ni L, Wang L, Jiang J, Wang Y, Wang DW.

J Am Heart Assoc. 2016 Nov 16;5(11). pii: e004190.


Impact of type 2 diabetes mellitus on hospitalization costs in older patients with acute myocardial infarction.

Fu KL, Fan GQ, Han L, Wang XZ, Wang J, Wang YS, Zhong M, Zhang Y, Zhang W, Wang ZH.

Clin Interv Aging. 2014 Apr 25;9:711-8. doi: 10.2147/CIA.S59802. eCollection 2014.


Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen.

Rinfret S, Kennedy WA, Lachaine J, Lemay A, Rodés-Cabau J, Cohen DJ, Costerousse O, Bertrand OF.

JACC Cardiovasc Interv. 2010 Oct;3(10):1011-9. doi: 10.1016/j.jcin.2010.07.011.


Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.

Yun H, Safford MM, Brown TM, Farkouh ME, Kent S, Sharma P, Kilgore M, Bittner V, Rosenson RS, Delzell E, Muntner P, Levitan EB.

J Am Heart Assoc. 2015 Feb 9;4(2). pii: e001208. doi: 10.1161/JAHA.114.001208.


Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention.

Glaser R, Gertz Z, Matthai WH, Wilensky RL, Weiner M, Kolansky D, Hirshfeld J Jr, Herrmann H.

J Invasive Cardiol. 2009 Sep;21(9):464-7.


Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan.

Lin ZF, Wang CY, Shen LJ, Hsiao FY, Lin Wu FL.

Can J Diabetes. 2016 Jun;40(3):264-9. doi: 10.1016/j.jcjd.2015.12.006. Epub 2016 Mar 15.


Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.

Meadows ES, Bae JP, Zagar A, Sugihara T, Ramaswamy K, McCracken R, Heiselman D.

BMC Res Notes. 2012 Jul 2;5:342. doi: 10.1186/1756-0500-5-342.


Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.

Molife C, Frech-Tamas F, DeKoven M, Effron MB, Karkare S, Zhu Y, Larmore C, Lu J, McCollam P, Marrett E, Vetrovec GW.

J Med Econ. 2015;18(11):898-908. doi: 10.3111/13696998.2015.1060979. Epub 2015 Jul 10.


Management of diabetic patients hospitalized for acute coronary syndromes: a prospective multicenter registry.

Ferlini M, Musumeci G, Demarchi A, Grieco N, Mafrici A, De Servi S, Rossini R, Sponzilli C, Bognetti P, Cardile A, Frattini S, Ielasi A, Russo A, Vecchiato C, Lettieri C, Visconti LO.

J Cardiovasc Med (Hagerstown). 2017 Aug;18(8):572-579. doi: 10.2459/JCM.0000000000000523.


Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention.

Jiménez-Navarro MF, Garcia-Pinilla JM, Garrido-Sanchez L, Alonso-Briales JH, Pérez-Cabeza A, Ortiz-García C, Hernández-Garcia JM, Tinahones F, de Teresa E.

Int J Cardiol. 2010 Jul 23;142(3):245-9. doi: 10.1016/j.ijcard.2009.01.020. Epub 2009 Feb 20.


Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.

Balakrishnan R, Berger JS, Tully L, Vani A, Shah B, Burdowski J, Fisher E, Schwartzbard A, Sedlis S, Weintraub H, Underberg JA, Danoff A, Slater JA, Gianos E.

Diabetes Metab Res Rev. 2015 Sep;31(6):603-9. doi: 10.1002/dmrr.2646. Epub 2015 May 12.


Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients.

Clavijo LC, Cortes GA, Jolly A, Tun H, Mehra A, Gaglia MA Jr, Shavelle D, Matthews RV.

Cardiovasc Revasc Med. 2016 Apr-May;17(3):155-61. doi: 10.1016/j.carrev.2016.03.003. Epub 2016 Mar 10.


Supplemental Content

Support Center